ClinicalTrials.govpublic full text
Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)
non-small cell lung cancer, imetelstat, imetelstat sodium, grn163l, telomerase inhibitor, telomerase inhibition, maintenance therapy, relapsed non-small cell lung cancer, advanced non-small cell lung cancer, nsclc, cancer stem cells, bevacizumab, post induction chemotherapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 906478
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.